The possibility of insider trading by Congressional officials is capturing headlines again — this time prompted by an academic study finding that Members of the House of Representatives had stock portfolios that outperformed those of average investors by about 6 percent annually.
This recent revelation comes in the wake of a 2004 study by the same four business school professors that found even greater, seemingly uncanny investment performances by Senators (about 12 percent annually). A front-page Wall Street Journal report in 2010 likewise raised questions about dozens of trades by legislative staffers.
Each of these studies appears to substantiate the well-worn claim that Congressional officials are immune from federal insider trading law. At least that is the conclusion drawn by many pundits, editors and journalists. Proposed legislation that has lain dormant for more than four years in the House — the Stop Trading on Congressional Knowledge Act (H.R. 1148, dubbed the STOCK Act) — is being heralded as the only way to prevent Congressional officials from using nonpublic Congressional knowledge to enrich their personal portfolios.
It is a specious claim. The conventional wisdom that there is some type of legal loophole for Congressional insider trading is simply wrong. Any Member of Congress or legislative staffer who trades securities on the basis of material nonpublic information obtained through Congressional service is already doing so in violation of existing federal securities law.
Congress has never actually enacted a federal securities law that explicitly defines or prohibits anyone from insider trading. Rather, Congress has been content to allow the offense to be prosecuted as a violation of Rule 10b-5 of the Securities Exchange Act of 1934, a general anti-fraud rule that prohibits deception “in connection with the purchase or sale of any security.”
The notion — accepted much too easily — that Congressional officials are not already prohibited from trading securities on the basis of Congressional knowledge is rooted in twin misconceptions.
Those are based on a lack of regard for the broad and sweeping duties of entrustment that attach to public office and an unduly restrictive view of the Supreme Court’s precedents, which have interpreted Rule 10b-5 to impose liability whenever a person trades securities on the basis of material nonpublic information in violation of a fiduciary-like duty of trust and confidence owed either to the issuer’s shareholders (the “classical theory” of insider trading) or to the source of the information (the “misappropriation theory”).
The (un)lawfulness of Congressional insider trading therefore turns on whether these officials owe duties of trust and confidence to others who would be deceived and defrauded by the self-serving use of nonpublic Congressional knowledge.
This question can be answered with a resounding yes.
Legislative staffers owe duties of trust and confidence to the Members of Congress who employ them. And Senators and Representatives stand in fiduciary-like relationships with the citizen-investors they were elected to serve. For proof, one need only consult the Constitution’s repeated references to public offices being “of trust.”
Consider also that Members of Congress have been imprisoned for bribery and kickback schemes that deprived the public of its right to receive honest services. Such convictions under the federal mail- and wire-fraud statutes presuppose that Congressional loyalty is a positive right and enforceable interest.
Rep. Bill Cassidy has his blood drawn by Alesha Barbour during a free hepatitis screening in the Rayburn House Office Building hosted by the Congressional Viral Hepatitis Caucus to recognize "National Viral Hepatitis Testing Day."
Roll Call has launched a new feature, Hill Navigator, to advise congressional staffers and would-be staffers on how to manage workplace issues on Capitol Hill. Please send us your questions anything from office etiquette, to handling awkward moments, to what happens when the work life gets too personal. Submissions will be treated anonymously.